HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
The American Cancer Society estimates that 2.9 million men who have been diagnosed with prostate cancer at some point in their lives are still alive today. And through clinical trials, that number will only increase over time. Regional Cancer Care Associates currently conducts more than 300 advanced clinical trials, putting our cancer physician networks on the front lines of treatment innovation for patients with prostate cancer. If you’re interested in learning more about prostate cancer clinical trials, call RCCA today at 201-669-4706.
As a type of research study, clinical trials are methodically designed tests that evaluate the effectiveness of new drugs, medical techniques and devices as they relate to the prevention, detection and treatment of prostate cancer and other diseases. Offered at the final stages of research and development of new therapies, clinical trials have been thoroughly vetted in a laboratory setting to ensure their safety before being offered to patients like you.
Medical treatment can be expensive, especially for patients with prostate cancer. However, when you enroll in a clinical trial, a sponsoring company will cover the cost of care associated with the trial. Besides being a cost-saving option for patients, clinical trials are also relatively safe. At RCCA, our clinical trial protocols are applied one-to-one to each patient. That means you get a personalized treatment plan that follows strict regulations and takes into account your situation.
What’s more, by participating in a clinical trial, you will help researchers learn about a new treatment or method that could one day help future patients with prostate cancer.
Before starting a clinical trial, you will also need to give RCCA informed consent. We’ll provide you with all the information you need about the trial –including its purpose, the therapies to be used and their associated risks and benefits–before you decide whether to participate.
With more than 30 locations throughout New Jersey, Connecticut, and Maryland, RCCA makes participation in advanced clinical trials available to communities throughout the Northeast. To see if you’re a good candidate for a prostate cancer clinical trial, make an appointment at RCCA today.
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.